Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls

被引:349
|
作者
Lyke, KE
Burges, R
Cissoko, Y
Sangare, L
Dao, M
Diarra, I
Kone, A
Harley, R
Plowe, CV
Doumbo, OK
Sztein, MB
机构
[1] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA
[2] Univ Bamako, Bandiagara Malaria Project, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Bamako, Mali
关键词
D O I
10.1128/IAI.72.10.5630-5637.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammatory cytokines play an important role in human immune responses to malarial disease. However, the role of these mediators in disease pathogenesis, and the relationship between host protection and injury remains unclear. A total of 248 cases of severe Plasmodium falciparum malaria among children aged 3 months to 14 years residing in Bandiagara, Mali, were matched to cases of uncomplicated malaria and healthy controls. Using modified World Health Organization criteria for defining severe malaria, we identified 100 cases of cerebral malaria (coma, seizure, and obtundation), 17 cases of severe anemia (hemoglobin, <5 g/dl), 18 cases combined cerebral malaria with severe anemia, and 92 cases with hyperparasitemia (asexual trophozoites, >500,000/mm(3)). Significantly elevated levels (given as geometric mean concentrations in picograms/ milliliter) of interleukin-6 (IL-6; 485.2 versus 54.1; P = <0.001), IL-10 (1,099.3 versus 14.1; P = <0.001), tumor necrosis factor alpha (10.1 versus 7.7; P = <0.001), and IL-12(p70) (48.9 versus 31.3; P = 0.004) in serum were found in severe cases versus healthy controls. Significantly elevated levels of IL-6 (485.2 versus 141.0; P = <0.001) and IL-10 (1,099.3 versus 133.9; P = <0.001) were seen in severe malaria cases versus uncomplicated malaria controls. Cerebral malaria was associated with significantly elevated levels of IL-6 (754.5 versus 311.4; P = <0.001) and IL-10 (1,405.6 versus 868.6; P = 0.006) compared to severe malaria cases without cerebral manifestations. Conversely, lower levels of IL-6 (199.2 versus 487.6; P = 0.03) and IL-10 (391.1 versus 1,160.9; P = 0.002) were noted in children with severe anemia compared to severe malaria cases with hemoglobin at >5 g/dl. Hyperparasitemia was associated with significantly lower levels of IL-6 (336.6 versus 602.1; P = 0.002). These results illustrate the complex relationships between inflammatory cytokines and disease in P. falciparum malaria.
引用
收藏
页码:5630 / 5637
页数:8
相关论文
共 50 条
  • [21] PRODUCTION OF HEMOLYMPHOPOIETIC CYTOKINES (IL-6, IL-8, COLONY-STIMULATING FACTORS) BY NORMAL HUMAN ASTROCYTES IN RESPONSE TO IL-1-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA
    ALOISI, F
    CARE, A
    BORSELLINO, G
    GALLO, P
    ROSA, S
    BASSANI, A
    CABIBBO, A
    TESTA, U
    LEVI, G
    PESCHLE, C
    JOURNAL OF IMMUNOLOGY, 1992, 149 (07): : 2358 - 2366
  • [22] Evaluation of changes in serum cytokine (TNFα, IFNα2, IFNγ, IL-1β, IL-6, IL-8, IL-10, IL-10, IL-12p70, IL-17A, IL-18, IL-23, IL-23, IL-33, and MCP-1) values in biologic-naive psoriasis patients during biologic agent use
    Bulut, Tutku
    Zorlu, Ozge
    Erdal, Berna
    Yilmaz, Bahar
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [23] INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE
    CASSATELLA, MA
    MEDA, L
    BONORA, S
    CESKA, M
    CONSTANTIN, G
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06): : 2207 - 2211
  • [24] 创伤脓毒症患者血浆中IL-12p70、TNF-α、IL-1b、IL-6、IL-8、IL-10的变化及其意义
    岳茂兴
    徐冰心
    李瑛
    卞晓星
    陆洁
    郑琦涵
    沈文明
    冯凯
    尹进南
    赵晓成
    中华创伤杂志, 2012, (12) : 1117 - 1119
  • [25] Association between Acne and Serum Pro-inflammatory Cytokines (IL-1α, IL-β3, IL-1Ra, IL-6, IL-8, IL-12 and RANTES) in Mustard Gas-Exposed Patients: Sardasht-Iran Cohort Study
    Askari, Nayere
    Ghazanfari, Tooba
    Yaraee, Roya
    Mahdavi, Mohammad Reza Vaez
    Soroush, Mohammad-Reza
    Hassan, Zuhair Mohammad
    Khodashenas, Zohre
    Shams, Jalaleddin
    Faghihzadeh, Soghrat
    ARCHIVES OF IRANIAN MEDICINE, 2017, 20 (02) : 86 - 91
  • [26] SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-1-BETA (IL-1-BETA) IN DENGUE-INFECTED PATIENTS
    HOBER, D
    POLI, L
    ROBLIN, B
    GESTAS, P
    CHUNGUE, E
    GRANIC, G
    IMBERT, P
    PECARERE, JL
    VERGEZPASCAL, R
    WATTRE, P
    MANIEZMONTREUIL, M
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 48 (03): : 324 - 331
  • [27] Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: High sensitivity of TNF alpha and resistance of IL-6
    DeRijk, R
    Michelson, D
    Karp, B
    Petrides, J
    Galliven, E
    Deuster, P
    Paciotti, G
    Gold, PW
    Sternberg, EM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07): : 2182 - 2191
  • [28] Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin
    Zhu, J
    Bai, XF
    Mix, E
    Link, H
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (01): : 85 - 94
  • [29] Association of Reduced Tumor Necrosis Factor Alpha, Gamma Interferon, and Interleukin-1β (IL-1β) but Increased IL-10 Expression with Improved Chest Radiography in Patients with Pulmonary Tuberculosis
    Su, Wen-Lin
    Perng, Wann-Cherng
    Huang, Ching-Hui
    Yang, Cheng-Yu
    Wu, Chin-Pyng
    Chen, Jenn-Han
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (02) : 223 - 231
  • [30] Perioperative serum levels of tumour-necrosis-factor alpha (TNF-α), IL-1β, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution
    Roth-Isigkeit, A
    von Borstel, T
    Seyfarth, M
    Schmucker, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (02): : 242 - 246